Esther H. Chang

Georgetown University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

56h-index11.9kcitations163works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA Interference and Gene Delivery(44), Cancer-related Molecular Pathways(31), Virus-based gene therapy research(27), Cancer Research and Treatments(21), MicroRNA in disease regulation(19)

Publications163 total

Enhanced Delivery of Aurora Kinase A Inhibitor Alisertib via Tumor-Targeting Immunoliposome Nanocomplex for Improved Treatment of Cancers Including Atypical Teratoid/Rhabdoid Tumor
International Journal of Nanomedicine·2026Open Access
BLID is a drug-responsive target of FOXO3a and multi-omics analysis reveals survival mechanisms and therapeutic vulnerabilities in BLID-deficient breast cancer cells
Oncology Letters·2025Open Access
RELT Is Upregulated in Breast Cancer and Induces Death in Breast Cancer Cells
Biomedicines·2024Open Access
Enhancing the Efficacy of Chemotherapeutic Drugs Via Encapsulation within Nanocomplexes Designed to Cross the Blood-Brain Barrier and Target Tumors
IntechOpen eBooks·2024Open Access
scL-2PAM: A Novel Countermeasure That Ameliorates Neuroinflammation and Neuronal Losses in Mice Exposed to an Anticholinesterase Organophosphate
International Journal of Molecular Sciences·2024· 2 citedOpen Access
SMARCB1 Gene Therapy Using a Novel Tumor-Targeted Nanomedicine Enhances Anti-Cancer Efficacy in a Mouse Model of Atypical Teratoid Rhabdoid Tumors
International Journal of Nanomedicine·2024· 6 citedOpen Access
Abstract 349: The role of RELTfms and FLNA in human cancer and cellular apoptosis
Cancer Research·2024
A Pralidoxime Nanocomplex Formulation Targeting Transferrin Receptors for Reactivation of Brain Acetylcholinesterase After Exposure of Mice to an Anticholinesterase Organophosphate
International Journal of Nanomedicine·2024· 7 citedOpen Access
CTIM-34. JACOB: JOINT ADMINISTRATION OF CDNA FOR <i>TP53</i>, CHECKPOINT INHIBITION, AND BOOST/HYPO FRACTIONATED RADIATION. A PHASE 0/1 STUDY IN CHILDREN WITH RECURRENT, PROGRESSIVE, OR REFRACTORY CNS MALIGNANCIES
Neuro-Oncology·2023Open Access
RELT is overexpressed in human inflammatory bowel disease and breast cancer
The Journal of Immunology·2023Open Access
Data from Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer
2023Open Access
Supplementary Data from Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer
2023Open Access
Supplementary Data from Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer
2023Open Access
Supplementary Data from Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer
2023Open Access
Supp Table S1, S3-8 from Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer
2023Open Access
Data from Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer
2023Open Access
Supp Table S1, S3-8 from Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer
2023Open Access
Supplementary Data from Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer
2023Open Access
A Novel P53 Nanomedicine Reduces Immunosuppression and Augments Anti-PD-1 Therapy for Non-Small Cell Lung Cancer in Syngeneic Mouse Models
Cells·2022· 16 citedOpen Access
Nanomedicine-Based Gene Delivery for a Truncated Tumor Suppressor RB94 Promotes Lung Cancer Immunity
Cancers·2022· 3 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Kathleen F. Pirollo(28), Antonina Rait(19), Douglas R. Lowy(10), Edward M. Scolnick(8), Sang Soo Kim(6), Liang Xu(5), Joe B. Harford(5), Wenhua Tang(4), Robert M. Friedman(4), Ronald Ellis(3), Laiman Xiang(3), Gordon L. Hager(3), John A. Dagata(3), Eric H. Kim(3), Robert A. Weinberg(2), Shiv Srivastava(2), Zhiqiang Zou(2), William A. Blattner(2), Deborah DeFeo(2), Jean Maryak(2)